Infectious pathogens in pediatric patients with primary immunodeficiencies

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 6, 2006, Pages 503-515

  Chang, Shu Hua ^a   Yang, Yao Hsu ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Etiology; Immunologic deficiency syndromes; Infection; Phagocytes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFIXIME; CEFPODOXIME PROXETIL;

ACUTE GASTROENTERITIS; ARTICLE; BACTEREMIA; BRONCHIOLITIS; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; INFANT; INFECTION; LYMPHADENITIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MICROBIAL IDENTIFICATION; OTITIS MEDIA; PHAGOCYTE; PNEUMONIA; PREVALENCE; SKIN ABSCESS; UNIVERSITY HOSPITAL; COMMUNICABLE DISEASE; EPIDEMIOLOGY; MICROBIOLOGY; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TAIWAN; TEACHING HOSPITAL;

CAUSALITY; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; HOSPITALS, TEACHING; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; PHAGOCYTES; RETROSPECTIVE STUDIES; TAIWAN;

EID: 33847730309     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987;9:334-56.
2. Gallin JI. Interferon-gamma in the management of chronic granulomatous disease. Rev Infect Dis 1991;13:973-8.
3. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321-33.
4. Parslow TG, Stites DP, Terr AI, Imboden JB, eds. Medical immunology. 10th ed. New York: McGraw-Hill; 2001:299-340.
5. Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 16th ed. Philadelphia, Pa: W.B. Saunders; 2000:596-626.
6. Yang CM, Yang YH, Lin YT, Lu MY, Chiang BL. Natural killer cell deficiency associated with Hodgkin's lymphoma: a case report. J Formos Med Assoc 2002;101:73-5.
7. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curmutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 2000;79:155-69.
8. Hsu CT, Lin YT, Yang YH, Chiang BL. The hyperimmunoglobulin E syndrome. J Microbiol Immunol Infect 2004;37:121-3.
9. Katz B, Waites K. Emerging intracellular bacterial infections. Clin Lab Med 2004;24:627-49.
10. Notarangelo L, Casanova JL, Fischer A, Puck J, Rosen F, Seger R, et al. Primary immunodeficiency diseases: An update. J Allergy Clin Immunol 2004;114:677-87.
11. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000;343:1313-24.
12. Buckley RH. Primary cellular immunodeficiencies. J Allergy Clin Immunol 2002;109:747-57.
13. Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, et al. Chronic granulomatous disease: A clinical survey of 41 patients from the Iranian primary immunodeficiency Registry. Int Arch Allergy Immunol 2004;134:253-9.
14. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985;64:145-56.
15. Hermans PE, Diaz-Buxo JA, Stobo JD. Idiopathic late-onset immunoglobulin deficiency: clinical observations in 50 patients. Am J Med 1976;61:221-37.
16. Cunningham-Rundles C. Clinical and immunologic analysis of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33.
17. Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol 2003;111:571-81.
18. Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 16th ed. Philadelphia, Pa: W. B. Saunders; 2000;833-7.
19. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 1985;145:1621-9.
20. Chusid MJ, Hillmann SM. Community-acquired Pseudomonas sepsis in previously healthy children. Pediatr Infect Dis J 1987;6:681-4.
21. Ng W, Yan CL, Yeow V, Yeo M, Teo SH. Ecthyma gangrenosum in a patient with hypogammaglobulinemia. J Infect 1998;36:331-5.
22. Wong SN, Tam AY, Yung RW, Kwan EY, Tsoi NN. Pseudomonas septicemia in apparently healthy children. Acta Paediatr Scand 1991;80:512-20.
23. Zomorrodi A, Wald ER. Ecthyma gangrenosum: considerations in a previously healthy child. Pediatr Infect Dis J 2002;21:1161-4.
24. Baro M, Marin MA, Ruiz-Contreras J, Miguel SF, Sanchez-Diaz I. Pseudomonas aeruginosa sepsis and ecthyma gangrenosum as initial manifestations of primary immunodeficiency. Eur J Pediatr 2004;163:173-4.
25. Blaser MJ, Perez GP, Smith PF, Patton C, Tenover FC, Lastovica AJ, et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis 1986;153:552-9.
26. Tokuda K, Nishi J, Miyanohara H, Sarantuya J, Iwashita M, Kamenosono A, et al. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient. Pediatr Infect Dis J 2004;23:577-9.
27. Ament ME, Ochs HD, Davis SD. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes: a study of 39 patients. Medicine 1973;52:227-48.
28. Good RA, Page AR. Fatal complications of virus hepatitis in two patients with agammaglobulinemia. Am J Med 1960;29:804-10.
29. Wilfert C, Buckley R, Mohanakumar T, Griffith JF, Katz SL, Whisnant JK, et al. Persistent and fatal central nervous system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med 1977;296:1485-9.
30. Rosen FS, Wedgwood RJ, Eibl M, Fischer A, Aiuti F, Notaragelo L, et al. Primary immunodeficiency diseases: report of a WHO scientific group. Clin Exp Immunol 1997;109(Suppl 1):1-28.
31. Buckley RH. Pulmonary complications of primary immunodeficiencies. Paediatr Resp Rev 2004;5(Suppl A);S225-33.
32. Soldatou A, Davies EG. Respiratory virus infections in the immunocompromised host. Paediatr Resp Rev 2003;4:193-204
33. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002;4:1545-58.
34. Chuck SL, Sande ML. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9.
35. Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM) Clin Exp Immunol 2000;120:399-405.
36. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
37. Banatvala N, Davies J, Kanarious M, Strobel S, Levinsky R, Morgan G. Hypogammaglobulinemia associated with normal or increased IgM (the hyper-IgM syndrome): a case series review. Arch Dis Child 1994;71:150-2.
38. Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998;92:2421-34.
39. Ballow M. Primary immunodeficiency disorders: Antibody deficiency. J Allergy Clin Immunol 2002;109:581-91.
40. Wang IJ, Wang SJ, Yan DC, Lin SJ, Chiang BL. Hyper-IgM syndrome: a case report. J Microbiol Immunol Infect 2003;36:215-7.
41. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 2004;144:505-11.
42. Junker AK, Driscoll DA. Humoral immunodeficiency in DiGeorge syndrome. J Pediatr 1995;127:231-7.
43. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004;113:620-6.
44. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170-200.
45. Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg 2002;235:383-91.
46. Soldatou A, Davies EG. Respiratory virus infections in the immunocompromised host. Paediatr Respir Rev 2003;4:193-204.
47. Festic E, Gajic O, Limper AH, Aksamit TR. Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection. Chest 2005;128:573-9.
48. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005;5:609-22.
49. Margolis DH, Melnick DA, Alling DW, Gallin JI. Trimethoprim- sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990;162:723-6.
50. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-16.
51. Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003;348:2416-22.
52. Conley ME, Saragousi D, Notaragelo L, Etzioni A, Casanova JL, and representing PAGID and ESID. An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 2003;109:272-7.
53. Leung DY, Geha RS. Clinical and immunological aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am 1988;2:81-100.